Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$26.77 USD
+0.04 (0.15%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $26.76 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.93 |
EPS Last Quarter | 0.98 |
Last EPS Surprise | 2.08% |
ABR | 1.50 |
Earnings ESP
|
1.08% |
---|---|
Current Year | 4.04 |
Next Year | 4.37 |
EPS (TTM) | 3.77 |
P/E (F1) | 6.62 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 598.60M | 665.31M | 2.68B | 2.90B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 608.28M | 671.79M | 2.69B | 2.93B |
Low Estimate | 588.92M | 658.82M | 2.67B | 2.86B |
Year ago Sales | 545.00M | 637.00M | 3.05B | 2.68B |
Year over Year Growth Est. | 9.83% | 4.44% | -12.02% | 8.01% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.93 | 0.91 | 4.04 | 4.37 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.94 | 0.91 | 4.20 | 4.74 |
Low Estimate | 0.92 | 0.90 | 3.89 | 4.02 |
Year ago EPS | 0.85 | 0.79 | 4.49 | 4.04 |
Year over Year Growth Est. | 9.41% | 15.19% | -10.02% | 7.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.93 | 0.91 | 4.04 | 4.37 |
7 Days Ago | 0.93 | 0.90 | 4.03 | 4.38 |
30 Days Ago | 0.93 | 0.90 | 4.03 | 4.40 |
60 Days Ago | 0.93 | 0.90 | 4.03 | 4.40 |
90 Days Ago | 0.90 | 0.89 | 3.95 | 4.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.94 | 0.90 | 4.05 | 4.24 |
Zacks Consensus Estimate | 0.93 | 0.91 | 4.04 | 4.37 |
Earnings ESP | 1.08% | -0.55% | 0.06% | -2.86% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.98 | 1.15 | 0.79 | 0.85 | NA |
Estimate | 0.96 | 1.03 | 0.81 | 0.83 | NA |
Difference | 0.02 | 0.12 | -0.02 | 0.02 | 0.04 |
Surprise | 2.08% | 11.65% | -2.47% | 2.41% | 3.42% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more